Precigen Inc. Aktie
Finanztrends
Deine Einschätzung
Precigen Inc. Aktie
Stark aufwärts geht es heute für die Precigen Inc. Aktie. Seit gestern notiert das Papier um 7,59 % höher.
Was spricht für und gegen Precigen Inc. in den nächsten Jahren?
Pro
?
U****************
?
M************
?
L*********** I********** f** d** n******* J****
Kontra
?
M****
?
W******* i* V********
?
A****************
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Precigen Inc. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Precigen Inc. | 7,59 % | 5,81 % | 3,66 % | 283,17 % | 37,39 % | 321,49 % | 11,21 % |
| Mighty River Power Ltd | 0,00 % | 0,00 % | 5,10 % | 10,00 % | 5,77 % | -8,33 % | -13,61 % |
| CEMIG ADR | 1,64 % | -1,59 % | 2,20 % | 16,25 % | 8,77 % | -19,83 % | 27,27 % |
| A2A SpA | 0,13 % | -3,24 % | 0,49 % | 6,07 % | -1,09 % | 30,91 % | 25,21 % |
Kommentare
News
What Does the Sale of Precigen Shares Worth $1.1 Million by the CFO Mean for Investors?
On July 1, 2026, Precigen (NASDAQ:PGEN) Chief Financial Officer Harry Thomasian Jr. reported the sale of 200,000 shares of common stock in multiple open-market transactions between June 29 and July
Is Precigen (PGEN) a Stock to Sell After Its CFO Let Go of 41,000 Shares?
Harry Thomasian Jr. Chief Financial Officer of Precigen (NASDAQ:PGEN), reported the sale of 41,884 shares of common stock on May 28, 2026, as disclosed in the SEC Form 4 filing.
Transaction value
Precigen Q1 Earnings Call Highlights
Precigen (NASDAQ:PGEN) reported a sharp increase in first-quarter 2026 revenue as the company’s first commercial product, PAPZIMEOS, continued its U.S. launch following FDA approval in August 2025
